INPLASY202340094

Evaluation of clinical and safety outcomes of neoadjuvant immunotherapy combined with chemoradiotherapy for patients with locally advanced rectal cancer:A meta-analysis of single-arm trials

Keywords: Rectal Neoplasms, Neoadjuvant chemoradiotherapy, programmed cell death 1 (PD-1), programmed cell death ligand 1 (PD-L1), immunotherapy , Systematic review.

Review Status: Ongoing